New test can identify dangerous bacteria with resistance to last-resort antibiotic

April 24, 2017, European Society of Clinical Microbiology and Infectious Diseases

New research suggests it is possible to quickly and accurately diagnose some the most dangerous and drug-resistant types of bacterial infections, using equipment already owned by most hospitals.

Bacteria have been gradually evolving to become resistant to the antibiotics used to treat them. Over the last few year, scientists have found evidence that some have become resistant to a last resort antibiotic called colistin.

Now, in a presentation at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), researchers described how they were able to test bacteria to quickly tell whether they were resistant to colistin, and how easily they might pass this resistance on to other bacteria. They say this is an important discovery because knowing which patients have these most dangerous infections means it is possible to use quarantine measures to halt their spread and stop the rise of drug resistance.

The research was presented by Dr Laurent Dortet, Associate Professor at South Paris University, France, and a researcher at Imperial College London, UK. The work was a collaboration between Dr Dortet and colleagues at Imperial, Dr Gerald Larrouy-Maumus and Professor Alain Filloux.

They studied bacteria called Escherichia coli and Klebsiella pneumoniae. These are both members of a group of bacteria called Enterobacteriacae that can cause gastroenteritis, , lung diseases such bronchitis and pneumonia, and even sepsis.

Some strains of these bacteria have become resistant to nearly all available antibiotics mostly by producing antibiotic inactivating enzymes, for example extended-spectrum -lactamases and carbapenemases. This means that colistin often remains the only treatment option for these . Unfortunately, some have now also developed resistance to colistin.

Previous research has shown two different types of colistin resistance exist in bacteria. One type, called chromosome-encoded resistance, can only be passed on when bacteria grow and divide to form new bacteria cells. The other type, called plasmid-encoded resistance, is considered more dangerous because it can be passed on from one type of bacteria to another completely different type of bacteria.

Dr Dortet told the congress: "This plasmid-encoded resistance is particularly worrying because it has the potential to spread quickly and easily and, if that happens, last resort drugs like colistin could also become obsolete. If, on the other hand, we are able to rapidly identify bacteria that have this type of resistance, we can take measures to stop its spread. This might include isolating the patient in a separate room where they are treated by dedicated medical staff."

The team tested 134 different colonies of bacteria using a machine called a mass spectrometer. Mass spectrometers are found in testing labs at most hospitals where they are used to analyse various different molecules.

They found that it was possible to distinguish not only between those bacteria that are colistin resistant, and those that are not, but also which bacteria have the more dangerous plasmid-encoded resistance. They say the test can be carried out in around 15 minutes and would cost less than one US dollar per sample.

Dr Larrouy-Maumus explained: "The exciting thing about this technique is that it relies on technology that is already available in most hospitals. This means that it could be rolled out quickly and cheaply, and potentially have a rapid impact on tackling drug-resistance."

The researchers are now working with Imperial Innovations, Imperial College London's technology transfer office, to patent the technique and develop it for widespread use in hospital laboratories.

They say the test could also be useful for screening in veterinary samples, where levels of colistin- are known to be high. It might also be used for testing whether new drugs are able restore bacteria's vulnerability to .

Explore further: Q&A: Superbug precursor found in US again

Provided by: European Society of Clinical Microbiology and Infectious Diseases

0 shares

Related Stories

Q&A: Superbug precursor found in US again

July 11, 2016
A New York City patient was infected with bacteria that had a special type of resistance to antibiotics last year, the earliest known case in the U.S. of bacteria that could lead to a superbug impervious to medications.

Multi-drug resistant bacteria in China

January 28, 2017
The mcr-1 gene—a gene that makes bacteria resistant to colistin, an antibiotic of last resort, and that is transferrable between bacteria—has been found in a wide variety of strains of Escherichia coli in China following ...

Rapid test detects mobile resistance gene mcr-1

February 6, 2017
Scientists from the German Center for Infection Research (DZIF) and the Justus Liebig University Giessen (JLU) have evaluated a rapid test that detects the dreaded colistin resistance gene within twenty minutes. It can therefore ...

Drug-resistant bacteria in patients' urine or stools raise risk of drug-resistant sepsis

April 23, 2017
People who have recently been found to have drug-resistant bacteria in their urine or stool samples have a greatly increased risk of developing a bloodstream infection that is also resistant to certain antibiotics, according ...

More cases of superbug precursor reported, but no spread

September 9, 2016
A fourth U.S. person has been diagnosed with bacteria resistant to a last resort antibiotic, but researchers are expressing relief that so far these superbug precursors have not spread to others.

The dirty dozen: UN issues list of 12 most worrying bacteria

February 27, 2017
The World Health Organization has issued a list of the top dozen bacteria most dangerous to humans, warning that doctors are fast running out of treatment options.

Recommended for you

As antibiotic resistance grows, researchers find new targets for fighting deadly staph infections

November 21, 2018
A new look at the inner-workings of bacterial cells could help researchers overcome deadly antibiotic resistance and save the lives of tens-of-thousands of people every year.

Scientists shed new light on infection process of the gastrointestinal pathogen C. difficile

November 21, 2018
Scientists from the VIB-UGent Center for Inflammation Research identified the mechanisms by which the bacterial pathogen Clostridium difficile kills intestinal epithelial cells (IECs), thus destroying the protective mucosal ...

Can liver disease be linked to heart failure? Study highlights liver-heart interaction

November 21, 2018
Virginia Commonwealth University researchers have collaborated on a clinical trial that identifies indicators for nonalcoholic fatty liver disease—a typically asymptomatic disease caused by fat buildup in the liver and ...

Researchers find infectious prions throughout eyes of patients with deadly sporadic Creutzfeldt-Jakob disease

November 20, 2018
By the time symptoms of sporadic Creutzfeldt-Jakob disease (sCJD) are typically discovered, death is looming and inevitable. But, in a new study, researchers at University of California San Diego School of Medicine with colleagues ...

Researchers a step closer to understanding how deadly bird flu virus takes hold in humans

November 19, 2018
New research has taken a step towards understanding how highly pathogenic influenza viruses such as deadly bird flu infect humans.

Infants born to obese mothers risk developing liver disease, obesity

November 16, 2018
Infant gut microbes altered by their mother's obesity can cause inflammation and other major changes within the baby, increasing the risk of obesity and non-alcoholic fatty liver disease later in life, according to researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.